Evogene Ltd. vs Regenxbio Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Regenxbio Inc. is the larger company by market value: $513 M against $8 M for Evogene Ltd., 64 times as much (market caps of Aug 1, 2026 for Evogene Ltd. and Oct 6, 2026 for Regenxbio Inc.). Evogene Ltd.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
- Regenxbio Inc. had more revenue: $170 M against $4 M for Evogene Ltd., both in the year to December 2025.
- Both made a net loss: $8 M for Evogene Ltd. and $194 M for Regenxbio Inc.
- Regenxbio Inc. keeps more of each dollar of sales: a net margin of -113.8% against -220.3% for Evogene Ltd.
- Regenxbio Inc.'s revenue grew faster in its latest fiscal year: +104.5% against -31.0% for Evogene Ltd.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Evogene Ltd. EVGN · #26,237 in the world | Regenxbio Inc. RGNX · #12,415 in the world |
|---|---|---|
| Profile | ||
| Country | 🇮🇱 Israel | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Founded | 2002 | — |
| Size | ||
| Market cap | $8 M | $513 M |
| Revenue | $4 M | $170 M |
| Net income | $-8 M▲ best | $-194 M |
| Employees | — | 372 |
| Valuation | ||
| Price to sales | 2.1× | 3.3× |
| Price to book | — | 5.0× |
| Free cash flow yield | -170.5% | -24.6%▲ best |
| Profitability | ||
| Gross margin | -6.2% | — |
| Operating margin | -364.4% | -94.6%▲ best |
| Net margin | -220.3% | -113.8%▲ best |
| Return on equity | — | -107.0% |
| Growth | ||
| Revenue growth | -31.0% | 104.5%▲ best |
| Revenue growth, 3 years a year | 31.8%▲ best | 14.8% |
| Cash | ||
| Free cash flow margin | -354.3% | -74.1%▲ best |
| Altman Z-score zone | — | distress |
| Data as of | Market cap Aug 2026; ratios FY2025 | Market cap Oct 2026; ratios FY2025 |
Questions and answers#
Which is bigger, Evogene Ltd. or Regenxbio Inc.?
Regenxbio Inc. is the larger company by market value: $513 M against $8 M for Evogene Ltd., 64 times as much (market caps of Aug 1, 2026 for Evogene Ltd. and Oct 6, 2026 for Regenxbio Inc.). Evogene Ltd.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
Which makes more money, Evogene Ltd. or Regenxbio Inc.?
Regenxbio Inc. had more revenue: $170 M against $4 M for Evogene Ltd., both in the year to December 2025. Both made a net loss: $8 M for Evogene Ltd. and $194 M for Regenxbio Inc.
Which is more profitable, Evogene Ltd. or Regenxbio Inc.?
Regenxbio Inc. keeps more of each dollar of sales: a net margin of -113.8% against -220.3% for Evogene Ltd.
Which is growing faster, Evogene Ltd. or Regenxbio Inc.?
Regenxbio Inc.'s revenue grew faster in its latest fiscal year: +104.5% against -31.0% for Evogene Ltd.